wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52901403-549AAB3D-E2F9-45F9-88AF-2BA002554017
Q52901403-549AAB3D-E2F9-45F9-88AF-2BA002554017
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52901403-549AAB3D-E2F9-45F9-88AF-2BA002554017
Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy.
P2860
Q52901403-549AAB3D-E2F9-45F9-88AF-2BA002554017
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52901403-549AAB3D-E2F9-45F9-88AF-2BA002554017
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16c01bce32bc7918781b448f9e32b08d5e6878e7
P2860
Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes